CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,365,393 | +72.7% | 1,336,934 | +4.1% | 0.02% | +60.0% |
| Q1 2023 | $29,736,498 | +91574.6% | 1,284,521 | +3.8% | 0.01% | 0.0% |
| Q4 2022 | $32,437 | -99.9% | 1,238,080 | +11.2% | 0.01% | +25.0% |
| Q3 2022 | $21,895,000 | +50.4% | 1,113,744 | +33.8% | 0.01% | +60.0% |
| Q2 2022 | $14,559,000 | +71.0% | 832,406 | +59.9% | 0.01% | +66.7% |
| Q1 2022 | $8,515,000 | +78.9% | 520,475 | +78.3% | 0.00% | +200.0% |
| Q4 2021 | $4,760,000 | +81.3% | 291,835 | +41.8% | 0.00% | 0.0% |
| Q3 2021 | $2,625,000 | +92.4% | 205,783 | +113.0% | 0.00% | – |
| Q2 2021 | $1,364,000 | +558.9% | 96,606 | +626.1% | 0.00% | – |
| Q1 2021 | $207,000 | -84.4% | 13,304 | -84.1% | 0.00% | – |
| Q4 2020 | $1,328,000 | – | 83,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |